EUVIMEDEUVIMED entdecken
Crossref

Generic UPLC-MS/MS and Gyrolab assays with blood microsampling for pharmacokinetic assessments of therapeutic antibodies in mice

Yuji Mano, Kenji Kita, Marina Tsugaru, Koichiro Hotta, Tomoko Kojima, Ken-Ichi Noritake

Journal of Pharmaceutical and Biomedical Analysis · 2024

DOI: 10.1016/j.jpba.2024.115993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2024. Verfasst von Yuji Mano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Global Drug Metabolism and Pharmacokinetics, Eisai Co., Ltd., Tokodai 5-1-3, Tsukuba, Ibaraki 300-2635, Japan; Laboratory of Genomics-based Drug Disc…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Eisai Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serial blood sampling from one animal is useful to understand relationship between pharmacokinetics (PK) and pharmacological or toxicological events in individual animals. To assess its feasibility in mice, two therapeutic antibodies were used to evaluate impacts by different blood sampling methods, sampling sites, and assay platforms on PK. Denosumab and Panitumumab were intravenously administered to mice and only 0.05 mL of blood sample per point was collected from jugular vein or tail vein. Blood samples were collected serially from a mouse or collected by traditional composite sampling from each mouse. Plasma concentrations of the two drugs were assayed by a generic ligand binding assay using Gyrolab or by a generic ultra-performance liquid chromatography with tandem mass spectrometry. The two assay platforms showed acceptable accuracy and precision and gave comparable PK parameters of the drugs, suggesting that both assays were successfully applied to the PK assessments. Comparable results in the PK profiles were noted between serial and composite blood samplings and differences in the two sampling sites did not impact PK. These findings suggest that microsampling combined with generic assays is useful to assess PK profiles of therapeutic antibodies in mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryMiceAnimalsChromatography, LiquidBlood Specimen CollectionDried Blood Spot Testing

Stichwörter der Autor:innen

LC-MSLigand binding assayMicrosamplingPharmacokineticsTherapeutic antibody

Autor:innen und Institutionen

  • Global Drug Metabolism and Pharmacokinetics, Eisai Co., Ltd., Tokodai 5-1-3, Tsukuba, Ibaraki 300-2635, Japan; Laboratory of Genomics-based Drug Discovery, Faculty of Medicine, Graduate School of Comprehensive Human Sci…
  • DMPK & Bioanalysis Unit, Sunplanet Co., Ltd., Tokodai 5-1-3, Tsukuba, Ibaraki 300-2635, Japan.
  • Drug Safety and Animal Care Technology Unit, Sunplanet Co., Ltd., Tokodai 5-1-3, Tsukuba, Ibaraki 300-2635, Japan.
  • Global Drug Metabolism and Pharmacokinetics, Eisai Co., Ltd., Tokodai 5-1-3, Tsukuba, Ibaraki 300-2635, Japan.

Förderung

  • Eisai Canada

Zitieren

APA

Mano, Y., Kita, K., Tsugaru, M., Hotta, K., Kojima, T., & Noritake, K. I. (2024). Generic UPLC-MS/MS and Gyrolab assays with blood microsampling for pharmacokinetic assessments of therapeutic antibodies in mice. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2024.115993

Vancouver

Mano Y, Kita K, Tsugaru M, Hotta K, Kojima T, Noritake KI. Generic UPLC-MS/MS and Gyrolab assays with blood microsampling for pharmacokinetic assessments of therapeutic antibodies in mice. Journal of Pharmaceutical and Biomedical Analysis. 2024. doi:10.1016/j.jpba.2024.115993

BibTeX
@article{Mano2024,
  author = {Mano, Yuji and Kita, Kenji and Tsugaru, Marina and Hotta, Koichiro and Kojima, Tomoko and Noritake, Ken-Ichi},
  title = {Generic UPLC-MS/MS and Gyrolab assays with blood microsampling for pharmacokinetic assessments of therapeutic antibodies in mice},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2024},
  doi = {10.1016/j.jpba.2024.115993}
}
Kostenlos starten →